Skip to content

SLU-PP-332

NAD+ & mitochondrialsmall moleculeEarly stage

Availability Not yet prescribable · sold for research use only

What it is

SLU-PP-332 is an experimental small molecule that activates the estrogen-related receptors, a family of nuclear receptors that switch on much of the genetic program exercise normally triggers in muscle. It came out of Thomas Burris's laboratory at Saint Louis University and picked up the label exercise mimetic, which is doing most of the selling.

Why people take it

The premise is hard to resist: the adaptations of endurance training without the training. Vendors sell it to people who want mitochondrial biogenesis, fat oxidation, and endurance on a schedule that does not include a schedule. It has also started appearing on frontier clinic lists as an early-stage compound to watch, which lends it a legitimacy the data do not.

How it's delivered

There is no approved formulation and no established human dose. The published mouse work used intraperitoneal injection at 50 mg per kilogram twice daily, and the compound's own developers have noted that it lacks oral bioavailability, which is an awkward fact for the capsules and oral solutions sold online. What arrives is unverified material.

Where the evidence stands

Mice, and only mice. The original report showed SLU-PP-332 activating the acute aerobic exercise gene program in skeletal muscle and increasing running endurance in treated animals. A follow-up in diet-induced obese and genetically obese mice found increased energy expenditure and fatty acid oxidation, reduced fat mass, and improved glucose handling over 28 days of twice-daily injection. There is no human trial, no human safety data, and no pharmacokinetic profile in people. The same laboratory has since worked on orally active successor compounds, which is the ordinary signal that the original molecule was not the finished article.

Estimated cost

No approved product exists, so there is no reference price. What is sold online is a compound never given to a human, and the oral formats on sale sit awkwardly beside the developers' own note that the molecule lacks oral bioavailability.

Who offers it

No clinic or telehealth provider we track offers SLU-PP-332 as a treatment, though it appears on at least one clinic's frontier watch list. It is sold online as unregulated product, a channel we do not list and cannot verify.

How we know

Recorded from the published literature and vendor listings on our last research pass. We list no referral path to this compound and are not compensated for this entry.

Go deeper

No SLU-PP-332 guide yet. The science of aging hub covers mitochondrial decline and why the effects of exercise have proven so difficult to reproduce in a molecule.

Explore the science of aging

Longevity.io is for educational purposes only and is not medical advice. We cover SLU-PP-332 because it is being sold, not because a compound that has never been given to a human is a reasonable thing to take. Nothing here should be read as a recommendation to obtain it.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint